Company intelligence / Profile preview

The EVERY Company

San Francisco, California, United Statesevery.com ↗

Ownership: Private
Development stage: Commercial

Overview

The EVERY Company has successfully commercialized animal-free egg white proteins using precision fermentation. Their first product, EVERY ClearEgg™, offers a highly soluble and neutral-tasting protein for use in beverages and foods. They have also developed other functional egg protein ingredients such as OvoBoost™ and OvoPro™. These products are marketed as sustainable alternatives to traditional animal-derived proteins with equivalent or superior functionality.

Therapeutic areas: Other
Modalities: Recombinant proteinsPrecision fermentation
Industry: Non-Drug Biotech

Drug pipeline

2 assets

OvoBoost

Commercial

1 more asset in the full pipeline.

Request access →

Partnerships

Ingredion IncorporatedZX Ventures/BioBrew division of AB InBev

Beyond the preview

Go deeper on The EVERY Company.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on The EVERY Company.

Explore the full profile